Advanced technologies, combined with an exponential increase in biomedical data and research, provide an unparalleled opportunity to unravel the mysteries of diseases that have gone untreated for too long. This gives us the chance to solve the most intractable challenges of drug discovery - like excessive costs, high failure rates, low efficacy and the time it takes to get new drugs to market. But only if we unite human and artificial intelligence in the service of this goal. If we bring the most advanced technologies together with cutting edge science we can decipher complex disease biology, de-risk drug development, and discover more effective therapies for patients in need. We can build a healthier world in which no disease goes untreated. This is the future we are creating at BenevolentAI.